Dr BERWYN CLARKE, chief scientific officer at Lab21, underlines the value of pharmacogenetics in optimising patient outcomes.
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
COMPANY INFORMATION
Nova Biomedical is a world leader in point of care and critical care in-vitro diagnostics. Our products include:
Stat Profile Prime Plus®
A critical care blood gas analyser featuring maintenance-free sensors and a 22-test menu including tests for ionized magnesium (iMg), creatinine, urea, estimated plasma...
Hilton Birmingham Metropole Hotel
26th - 27th November 2024
Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024
TBA, Leeds
7th December 2024
The National Conference Centre, Birmingham
11th February 2025
Kia Oval, London
11th March 2025, 9:00am - 4:00pm
The National Conference Centre, Birmingham
29th – 30th April 2025
